Farallon presses Astellas to cut costs and overhaul drugs research in latest shareholder campaign gripping Tokyo ...
Private equity firm expects $3.3bn acquisition of Tanabe will get boost from eased approval process for new medicine ...
Following rumblings of a private equity bidding war late last year, Bain Capital has emer | Bain Capital is laying out 510 ...
Japan's Kobayashi Pharmaceutical says its looking at possible links between 80 deaths and its benikoji red yeast supplements.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果